search
Back to results

Sleep Improvement Intervention for Hospitalized Antepartum Patients

Primary Purpose

Sleep Disturbance in Hospitalized Antepartum Patients

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sleep Improvement Protocol Intervention for Hospitalized Antepartum Patients
Sponsored by
Sam Houston State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Disturbance in Hospitalized Antepartum Patients

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • speak, read, and write English
  • medically stable
  • 20 weeks' gestation or greater
  • viable fetus
  • hospitalized at least 24 hours

Exclusion Criteria:

  • Do not speak, read, and write English
  • Medically unstable
  • Less than 20 weeks' gestation
  • Nonviable fetus
  • Hospitalized less than 24 hours

Sites / Locations

  • Memorial Hermann Texas Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Sleep Improvement Intervention

Standard of Care (Control)

Arm Description

Outcomes

Primary Outcome Measures

Number of patients who use the sleep improvement intervention
Level of satisfaction with the intervention as assessed by a Likert assessment
The scale ranges from 0-5 with 5 being extremely satisfied

Secondary Outcome Measures

Full Information

First Posted
July 21, 2020
Last Updated
July 31, 2023
Sponsor
Sam Houston State University
Collaborators
The University of Texas Health Science Center, Houston, Memorial Hermann Texas Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04485728
Brief Title
Sleep Improvement Intervention for Hospitalized Antepartum Patients
Official Title
Sleep Improvement Intervention for Hospitalized Antepartum Patients
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 11, 2022 (Actual)
Primary Completion Date
July 31, 2022 (Actual)
Study Completion Date
January 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sam Houston State University
Collaborators
The University of Texas Health Science Center, Houston, Memorial Hermann Texas Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This project seeks to further study the effects of a hospital-based protocol for improving sleep in high-risk antepartum patients as piloted by Lee and Gay (2017).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disturbance in Hospitalized Antepartum Patients

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sleep Improvement Intervention
Arm Type
Experimental
Arm Title
Standard of Care (Control)
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Sleep Improvement Protocol Intervention for Hospitalized Antepartum Patients
Intervention Description
Patients are getting sleep hygiene education and a sleep hygiene kit.
Primary Outcome Measure Information:
Title
Number of patients who use the sleep improvement intervention
Time Frame
Day 7
Title
Level of satisfaction with the intervention as assessed by a Likert assessment
Description
The scale ranges from 0-5 with 5 being extremely satisfied
Time Frame
Day 7

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: speak, read, and write English medically stable 20 weeks' gestation or greater viable fetus hospitalized at least 24 hours Exclusion Criteria: Do not speak, read, and write English Medically unstable Less than 20 weeks' gestation Nonviable fetus Hospitalized less than 24 hours
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrea M Smith, Ph.D., RN
Organizational Affiliation
Sam Houston State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial Hermann Texas Medical Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Sleep Improvement Intervention for Hospitalized Antepartum Patients

We'll reach out to this number within 24 hrs